Dr. Keren B Sturtz MD
Hematologist-Oncologist | Hematology & Oncology
3655 Lutheran Pkwy Suite 406 Wheat Ridge CO, 80033About
Dr. Keren Sturtz is a hematologist oncologist practicing in Wheat Ridge, CO. Dr. Sturtz specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Provider Details
Clinical Trials
- Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
- Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
- S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
- Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia
- Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
- Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
- Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
- Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
- Breast Cancer WEight Loss Study (BWEL Study)
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
- Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
- Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
- Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
- S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
- Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
- Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
- Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
- Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
- PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
- S0820, Adenoma and Second Primary Prevention Trial
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
- Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
- S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
- Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
- Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Stage III-IVB Head and Neck Cancer Who Cannot Take Cisplatin
- Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
- Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Lung Cancer
- Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
- Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
- Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
- Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
- Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
- Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
- Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
- Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
- Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
- Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
- Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Dr. Keren B Sturtz MD's Practice location
Dr. Keren B Sturtz MD's reviews
Write ReviewPatient Experience with Dr. Sturtz
Recommended Articles
- Treatment Options of Multiple Myeloma
A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...
- What Are Lymphocytes?
A lymphocyte is a type of white blood cell (WBC) that has a significant function in the body's immune system. Lymphocytes function by properly responding to infectious microorganisms and other foreign invaders in the body. Lymphocytes can work alone, but some of them are also capable of...
- John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society
Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...
- Treatments for Multiple Myeloma
The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...
- Living as a Hodgkin Lymphoma Survivor: Creating a New Normal
No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...
- Lymphoma: The Importance of a Support System & Communication
Regardless of what’s being said, communication is something that many people struggle with in their personal relationships. Communication requires self-awareness, listening skills, and the ability to empathize and convey thoughts and feelings accurately. When people are diagnosed with chronic...
Nearby Providers
- Dr. Devchand Paul PHD DO4700 Hale Pkwy Denver CO 80220
- Dr. Muhammad Siddique MBBS7750 S BROADWAY LITTLETON CO 80122
- Dr. SARA ROBINSON M.D.University Of Colorado Denver CO 80262
- Dr. Tomer Mark MD, MSC12605 E 16TH AVE AURORA CO 80045
- Dr. Peter Kabos MD1665 Aurora Ct Aurora CO 80045
- Dr. Elaine Lam MD12605 E 16th Ave Aurora CO 80045